Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cells for Alport Syndrome [Phase 2, Phase 3]

View source ↗

Summary

The document describes an ongoing Phase 2/Phase 3 clinical trial evaluating human umbilical cord mesenchymal stem cells for Alport syndrome, with status not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alport Syndrome

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Guangzhou Women and Children's Medical Center | Conditions: Alport Syndrome | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING